Dr Jay L Faurot Iii, MD | |
404 Keene St, Columbia, MO 65201 | |
(572) 445-7300 | |
(573) 445-7301 |
Full Name | Dr Jay L Faurot Iii |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | 404 Keene St, Columbia, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265599823 | NPI | - | NPPES |
050042925 | Other | MO | RR MEDICARE |
20610907 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 103138 (Missouri) | Primary |
207L00000X | Anesthesiology | 26300 (Missouri) | Secondary |
Entity Name | Columbia Orthopaedic Group, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851392542 PECOS PAC ID: 9335042811 Enrollment ID: O20040130001024 |
News Archive
U.S. community hospitals billed insurance companies and federal and state programs $1.2 trillion in 2008 for inpatient care, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Merck & Co., Inc. said today that a mistrial was declared by U.S. District Court Judge John F. Keenan in Boles v. Merck, the first FOSAMAX case to go to trial. This case was the Plaintiffs' Steering Committee's first choice to take to trial. The Boles case was tried in New York federal court and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
Syneron Medical Ltd., the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products.
Researchers at National Jewish Health have identified a simple gene-based blood test that more accurately and quickly measures cystic fibrosis patients' response to therapy than current tests.
› Verified 9 days ago
Entity Name | Mid-missouri Anesthesiologists, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518929157 PECOS PAC ID: 4880651504 Enrollment ID: O20041214001188 |
News Archive
U.S. community hospitals billed insurance companies and federal and state programs $1.2 trillion in 2008 for inpatient care, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Merck & Co., Inc. said today that a mistrial was declared by U.S. District Court Judge John F. Keenan in Boles v. Merck, the first FOSAMAX case to go to trial. This case was the Plaintiffs' Steering Committee's first choice to take to trial. The Boles case was tried in New York federal court and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
Syneron Medical Ltd., the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products.
Researchers at National Jewish Health have identified a simple gene-based blood test that more accurately and quickly measures cystic fibrosis patients' response to therapy than current tests.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jay L Faurot Iii, MD Po Box 7536, Columbia, MO 65205 Ph: (573) 445-7300 | Dr Jay L Faurot Iii, MD 404 Keene St, Columbia, MO 65201 Ph: (572) 445-7300 |
News Archive
U.S. community hospitals billed insurance companies and federal and state programs $1.2 trillion in 2008 for inpatient care, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Merck & Co., Inc. said today that a mistrial was declared by U.S. District Court Judge John F. Keenan in Boles v. Merck, the first FOSAMAX case to go to trial. This case was the Plaintiffs' Steering Committee's first choice to take to trial. The Boles case was tried in New York federal court and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
Syneron Medical Ltd., the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products.
Researchers at National Jewish Health have identified a simple gene-based blood test that more accurately and quickly measures cystic fibrosis patients' response to therapy than current tests.
› Verified 9 days ago
Sarah Marie Von Thaer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
Ryan Daniel Montgomery, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
Thomas Wesley Meyer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 E Broadway, Columbia, MO 65201 Phone: 573-815-6262 Fax: 573-815-2308 | |
Dr. Oleksiy Mykhaylovych Zyernov, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Dc056.20, Columbia, MO 65212 Phone: 573-882-2568 Fax: 885-903-0985 | |
Frederick T O'donnell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65201 Phone: 573-882-2568 Fax: 573-882-2226 | |
Stephanie Elizabeth Cain, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-3466 | |
Eric Kenneth Jagim, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 573-882-2226 |